Literature DB >> 9158120

An acute phase reaction in diabetic patients with foot ulcers.

G R Upchurch1, B A Keagy, G Johnson.   

Abstract

The acute phase reaction is a molecular response to noxious stimuli. Over 50 glycoproteins have been identified as reactants. While this is likely a protective response, some of the changes could be detrimental to body homeostasis. The objective of this study was to examine whether an acute phase reaction occurs in diabetic patients with foot ulcers. In age- and sex-matched populations, measurements of C-reactive protein, fibrinogen, albumin, hematocrit, whole blood viscosity and protein C were performed on: (i) 24 diabetic patients with a foot ulcer (group A); (ii) eight diabetic patients without foot ulcer (group B); and (iii) seven patients without diabetes (group C). Analysis of variance was used to compare means of each respective group (mean (s.d.)). Group A demonstrated an increase in C-reactive protein (5.6 (5.4) mg/dl) compared with group B (0.78 (0.46) mg/dl; P = 0.013) and group C (0.71 (0.26) mg/dl; P = 0.026). Fibrinogen was also increased in group A (619 (205) mg/dl) compared with group B (310 (58) mg/dl; P = 0.005) and group C (370 (88) mg/dl; P = 0.04). Hematocrit (37 (6)%) and albumin (3.5 (0.5) g/dl) were decreased in group A compared with group B (hematocrit 46 (4)%; P < 0.0001; albumin 4.3 (0.3) g/dl; P = 0.0005) and group C (hematocrit 45 (3)%; P = 0.005; albumin 4.6 (0.3) g/dl; P < 0.0001). No difference was found in whole blood viscosity and levels of protein C. There also was no significant difference demonstrated between any of the parameters studied when comparing groups B and C. In conclusion, these results indicate that diabetic patients with a foot ulcer undergo an acute phase reaction as evidenced by a rise in C-reactive protein and fibrinogen compared with diabetic patients without a foot ulcer and normal control patients. As more is learned about the acute phase reaction, this information may prove valuable in the management of the diabetic patient.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158120     DOI: 10.1016/s0967-2109(96)00070-1

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  5 in total

1.  The role of procalcitonin as a marker of diabetic foot ulcer infection.

Authors:  Mafalda Massara; Giovanni De Caridi; Raffaele Serra; David Barillà; Andrea Cutrupi; Alberto Volpe; Francesco Cutrupi; Antonino Alberti; Pietro Volpe
Journal:  Int Wound J       Date:  2015-10-28       Impact factor: 3.315

Review 2.  Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot.

Authors:  Anthony R Berendt; Benjamin Lipsky
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

3.  Predictive factors for lower extremity amputations in diabetic foot infections.

Authors:  Zameer Aziz; Wong Keng Lin; Aziz Nather; Chan Yiong Huak
Journal:  Diabet Foot Ankle       Date:  2011-09-20

4.  Immune mediators in patients with acute diabetic foot syndrome.

Authors:  Christian Weigelt; Bettina Rose; Ulrike Poschen; Dan Ziegler; Gerd Friese; Kerstin Kempf; Wolfgang Koenig; Stephan Martin; Christian Herder
Journal:  Diabetes Care       Date:  2009-06-09       Impact factor: 19.112

5.  Blood viscosity and the expression of inflammatory and adhesion markers in homozygous sickle cell disease subjects with chronic leg ulcers.

Authors:  Andre S Bowers; Harvey L Reid; Andre Greenidge; Clive Landis; Marvin Reid
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.